Indiana to receive $16.5M in national opioid settlement involving eight drugmakers. AG Rokita proud of efforts to hold responsible parties accountable.

A recently launched video series from the Biotechnology Innovation Organization (BIO) seeks to show how biotech may be able ...

Indiana Attorney General Todd Rokita has secured $720 million in settlements with eight drug makers that manufacture opioid pills, with Indiana expected to receive $16.5 million, to hold accountable ...

Aurobindo, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir. Aurobindo, Cipla and ...

Attorney General Todd Rokita announced Monday that Indiana is expected to receive $16.5 million as part of a multi-state ...

Viatris in Egypt, a part of global healthcare company Viatris, announced the launch of Norvasc Val, a combination therapy for ...

DUSA offers a high conviction, value-focused approach with a concentrated portfolio. Learn more about DUSA ETF and my ...

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

Tariffs, and their potential detrimental impacts on vehicle affordability, company profits, global competitiveness, and ...

DelveInsight's CD40/CD40L Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Latanoprostene bunod 0.024% significantly reduced IOP across patient groups and appeared well regarded among physicians and ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...